Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death
Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death
Status: Enrolling
Updated:  5/15/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death
Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death
Status: Enrolling
Updated: 5/15/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Rifaximin Vaginal Tablets in the Treatment of Bacterial Vaginosis
Status: Enrolling
Updated:  6/17/2015
College of Medicine Drexel University
mi
from
Philadelphia, PA
Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Rifaximin Vaginal Tablets in the Treatment of Bacterial Vaginosis
Status: Enrolling
Updated: 6/17/2015
College of Medicine Drexel University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
Status: Enrolling
Updated:  6/22/2015
Akron Dermatology
mi
from
Akron, OH
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
Status: Enrolling
Updated: 6/22/2015
Akron Dermatology
mi
from
Akron, OH
Click here to add this to my saved trials
Physician Preference Study of ShuntCheck - Madsen
Physician Preference Study of the Utility of ShuntCheck to Detect Cerebrospinal Fluid (CSF) in Patients With Ventriculo-Peritoneal CSF Shunts
Status: Enrolling
Updated:  6/22/2015
Children's Hospital Boston
mi
from
Boston, MA
Physician Preference Study of ShuntCheck - Madsen
Physician Preference Study of the Utility of ShuntCheck to Detect Cerebrospinal Fluid (CSF) in Patients With Ventriculo-Peritoneal CSF Shunts
Status: Enrolling
Updated: 6/22/2015
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
CRT ShuntCheck "Fit & Function" Study
CRT ShuntCheck "Fit & Function" Exploratory Study
Status: Enrolling
Updated:  6/22/2015
LifeBridge Health, Sinai Hospital of Baltimore (Testing Adult Patients 35 years+)
mi
from
Baltimore, MD
CRT ShuntCheck "Fit & Function" Study
CRT ShuntCheck "Fit & Function" Exploratory Study
Status: Enrolling
Updated: 6/22/2015
LifeBridge Health, Sinai Hospital of Baltimore (Testing Adult Patients 35 years+)
mi
from
Baltimore, MD
Click here to add this to my saved trials
CRT ShuntCheck "Fit & Function" Study
CRT ShuntCheck "Fit & Function" Exploratory Study
Status: Enrolling
Updated:  6/22/2015
Johns Hopkins Hospital (Testing Pediatric Patients Age 3 to 19)
mi
from
Baltimore, MD
CRT ShuntCheck "Fit & Function" Study
CRT ShuntCheck "Fit & Function" Exploratory Study
Status: Enrolling
Updated: 6/22/2015
Johns Hopkins Hospital (Testing Pediatric Patients Age 3 to 19)
mi
from
Baltimore, MD
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
Mayo Clinic Florida
mi
from
Jacksonville, FL
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
Tufts Medical Center
mi
from
Boston, MA
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
Jewish Hospital
mi
from
Cincinnati, OH
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
Jewish Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
Geisinger Medical Center
mi
from
Danville, PA
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
Froedtert and the Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
Northwestern University
mi
from
Chicago, IL
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
Siouxland Hematology Oncology Associates
mi
from
Sioux City, IA
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
Siouxland Hematology Oncology Associates
mi
from
Sioux City, IA
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
Johns Hopkins University - Sidney Kimmel Comprehensive Cancer Center
mi
from
Baltimore, MD
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
Johns Hopkins University - Sidney Kimmel Comprehensive Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
The Mayo Clinic
mi
from
Rochester, MN
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
Geisinger Medical Center-Cancer Center Hazleton
mi
from
Hazleton, PA
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
Geisinger Medical Center-Cancer Center Hazleton
mi
from
Hazleton, PA
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
Lewistown Hospital
mi
from
Lewistown, PA
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
Lewistown Hospital
mi
from
Lewistown, PA
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
Geisinger Medical Group
mi
from
State College, PA
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
Geisinger Medical Group
mi
from
State College, PA
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
Mount Nittany Medical Center
mi
from
State College, PA
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
Mount Nittany Medical Center
mi
from
State College, PA
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
Geisinger Wyoming Valley Medical Center
mi
from
Wilkes-Barre, PA
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
Geisinger Wyoming Valley Medical Center
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  7/2/2015
Rambam Medical Center
mi
from
Haifa,
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults With Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 7/2/2015
Rambam Medical Center
mi
from
Haifa,
Click here to add this to my saved trials
Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome
Status: Enrolling
Updated:  7/6/2015
Florida University
mi
from
Gainesville, FL
Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome
Status: Enrolling
Updated: 7/6/2015
Florida University
mi
from
Gainesville, FL
Click here to add this to my saved trials
Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome
Status: Enrolling
Updated:  7/6/2015
Winthrop University
mi
from
Mineola, NY
Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome
Status: Enrolling
Updated: 7/6/2015
Winthrop University
mi
from
Mineola, NY
Click here to add this to my saved trials
Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome
Status: Enrolling
Updated:  7/6/2015
Vanderbilt University
mi
from
Nashville, TN
Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome
Status: Enrolling
Updated: 7/6/2015
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk
A Nested Case-Controlled Study Evaluating the Utility of Placental Protein 13 (PP13) In-vitro Diagnostic Kit as a Diagnostic Aiding Tool in Assessment of the Risk for Developing Preeclampsia Necessitating Delivery Before 37 Weeks (Early-preeclampsia) Based on First Trimester Blood Testing of Pregnant Women With Low and Unknown Risk
Status: Enrolling
Updated:  7/7/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk
A Nested Case-Controlled Study Evaluating the Utility of Placental Protein 13 (PP13) In-vitro Diagnostic Kit as a Diagnostic Aiding Tool in Assessment of the Risk for Developing Preeclampsia Necessitating Delivery Before 37 Weeks (Early-preeclampsia) Based on First Trimester Blood Testing of Pregnant Women With Low and Unknown Risk
Status: Enrolling
Updated: 7/7/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Therapy to Prevent Sexual Pain in Breast Cancer Survivors
Therapy to Prevent Sexual Pain in Menopausal Survivors of Breast Cancer
Status: Enrolling
Updated:  7/7/2015
Oregon Health and Science University
mi
from
Portland, OR
Therapy to Prevent Sexual Pain in Breast Cancer Survivors
Therapy to Prevent Sexual Pain in Menopausal Survivors of Breast Cancer
Status: Enrolling
Updated: 7/7/2015
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
Cross-Sectional Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
Status: Enrolling
Updated:  7/7/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
Cross-Sectional Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
Status: Enrolling
Updated: 7/7/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Duragen Versus Duraguard in Chiari Surgery
Prospective Randomized Study of Duragen vs. Duraguard in Chiari Surgery
Status: Enrolling
Updated:  7/8/2015
University of Illinois Medical Center, Chicago
mi
from
Chicago, IL
Duragen Versus Duraguard in Chiari Surgery
Prospective Randomized Study of Duragen vs. Duraguard in Chiari Surgery
Status: Enrolling
Updated: 7/8/2015
University of Illinois Medical Center, Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Diazepam Vaginal Suppositories for High Tone Pelvic Floor Dysfunction.
Diazepam Vaginal Suppositories as a Treatment Option for High Tone PElvic Floor Dysfunction: A Randomized Controlled Trial.
Status: Enrolling
Updated:  7/9/2015
Good Samaritan Hospital
mi
from
Cincinnati, OH
Diazepam Vaginal Suppositories for High Tone Pelvic Floor Dysfunction.
Diazepam Vaginal Suppositories as a Treatment Option for High Tone PElvic Floor Dysfunction: A Randomized Controlled Trial.
Status: Enrolling
Updated: 7/9/2015
Good Samaritan Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Correlating Time-Lapse Parameters With aCGH Testing in IVF Treatment (aCGH Study)
Correlating Time-Lapse Parameters Detected by Eeva™ With Array-Comparative Genomic Hybridization Results and Ongoing Pregnancy Rates (aCGH Study)
Status: Enrolling
Updated:  7/9/2015
Main Line Fertility
mi
from
Bryn Mawr, PA
Correlating Time-Lapse Parameters With aCGH Testing in IVF Treatment (aCGH Study)
Correlating Time-Lapse Parameters Detected by Eeva™ With Array-Comparative Genomic Hybridization Results and Ongoing Pregnancy Rates (aCGH Study)
Status: Enrolling
Updated: 7/9/2015
Main Line Fertility
mi
from
Bryn Mawr, PA
Click here to add this to my saved trials
Eeva System Imaging Study
Prospective Observational Study Utilizing the Eeva™ System 2.2.1 for Ongoing Collection of Development and Validation Data
Status: Enrolling
Updated:  7/9/2015
FCI (River North)
mi
from
Chicago, IL
Eeva System Imaging Study
Prospective Observational Study Utilizing the Eeva™ System 2.2.1 for Ongoing Collection of Development and Validation Data
Status: Enrolling
Updated: 7/9/2015
FCI (River North)
mi
from
Chicago, IL
Click here to add this to my saved trials
Eeva System Imaging Study
Prospective Observational Study Utilizing the Eeva™ System 2.2.1 for Ongoing Collection of Development and Validation Data
Status: Enrolling
Updated:  7/9/2015
Midwest Fertility Specialists
mi
from
Carmel, IN
Eeva System Imaging Study
Prospective Observational Study Utilizing the Eeva™ System 2.2.1 for Ongoing Collection of Development and Validation Data
Status: Enrolling
Updated: 7/9/2015
Midwest Fertility Specialists
mi
from
Carmel, IN
Click here to add this to my saved trials
Eeva System Imaging Study
Prospective Observational Study Utilizing the Eeva™ System 2.2.1 for Ongoing Collection of Development and Validation Data
Status: Enrolling
Updated:  7/9/2015
University of Iowa
mi
from
Iowa City, IA
Eeva System Imaging Study
Prospective Observational Study Utilizing the Eeva™ System 2.2.1 for Ongoing Collection of Development and Validation Data
Status: Enrolling
Updated: 7/9/2015
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Eeva System Imaging Study
Prospective Observational Study Utilizing the Eeva™ System 2.2.1 for Ongoing Collection of Development and Validation Data
Status: Enrolling
Updated:  7/9/2015
Texas Fertility Center
mi
from
Austin, TX
Eeva System Imaging Study
Prospective Observational Study Utilizing the Eeva™ System 2.2.1 for Ongoing Collection of Development and Validation Data
Status: Enrolling
Updated: 7/9/2015
Texas Fertility Center
mi
from
Austin, TX
Click here to add this to my saved trials
Eeva System Imaging Study
Prospective Observational Study Utilizing the Eeva™ System 2.2.1 for Ongoing Collection of Development and Validation Data
Status: Enrolling
Updated:  7/9/2015
Houston Fertility Institute
mi
from
Houston, TX
Eeva System Imaging Study
Prospective Observational Study Utilizing the Eeva™ System 2.2.1 for Ongoing Collection of Development and Validation Data
Status: Enrolling
Updated: 7/9/2015
Houston Fertility Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Eeva System Imaging Study
Prospective Observational Study Utilizing the Eeva™ System 2.2.1 for Ongoing Collection of Development and Validation Data
Status: Enrolling
Updated:  7/9/2015
Seattle Reproductive Medicine
mi
from
Seatlle, WA
Eeva System Imaging Study
Prospective Observational Study Utilizing the Eeva™ System 2.2.1 for Ongoing Collection of Development and Validation Data
Status: Enrolling
Updated: 7/9/2015
Seattle Reproductive Medicine
mi
from
Seatlle, WA
Click here to add this to my saved trials
Eeva System Imaging Study
Prospective Observational Study Utilizing the Eeva™ System 2.2.1 for Ongoing Collection of Development and Validation Data
Status: Enrolling
Updated:  7/9/2015
Fertility Associates
mi
from
Wellington,
Eeva System Imaging Study
Prospective Observational Study Utilizing the Eeva™ System 2.2.1 for Ongoing Collection of Development and Validation Data
Status: Enrolling
Updated: 7/9/2015
Fertility Associates
mi
from
Wellington,
Click here to add this to my saved trials
Behavioral Change in the Mother-Infant Dyad: Preventing Postpartum Depression
Behavioral Change in the Mother-Infant Dyad: Preventing Postpartum Depression
Status: Enrolling
Updated:  7/13/2015
Columbia University Medical Center
mi
from
New York, NY
Behavioral Change in the Mother-Infant Dyad: Preventing Postpartum Depression
Behavioral Change in the Mother-Infant Dyad: Preventing Postpartum Depression
Status: Enrolling
Updated: 7/13/2015
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Delayed Start to Ovarian Stimulation
Delayed Start to Ovarian Stimulation Improves Oocyte Maturation and Quality: A Randomized Trial
Status: Enrolling
Updated:  7/17/2015
UCSF Center for Reproductive Health
mi
from
San Francisco, CA
Delayed Start to Ovarian Stimulation
Delayed Start to Ovarian Stimulation Improves Oocyte Maturation and Quality: A Randomized Trial
Status: Enrolling
Updated: 7/17/2015
UCSF Center for Reproductive Health
mi
from
San Francisco, CA
Click here to add this to my saved trials
Delayed Start to Ovarian Stimulation
Delayed Start to Ovarian Stimulation Improves Oocyte Maturation and Quality: A Randomized Trial
Status: Enrolling
Updated:  7/17/2015
UCSF Center for Reproductive Health
mi
from
San Francisco, CA
Delayed Start to Ovarian Stimulation
Delayed Start to Ovarian Stimulation Improves Oocyte Maturation and Quality: A Randomized Trial
Status: Enrolling
Updated: 7/17/2015
UCSF Center for Reproductive Health
mi
from
San Francisco, CA
Click here to add this to my saved trials
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
Status: Enrolling
Updated:  7/17/2015
Oklahoma University
mi
from
Oklahoma City, OK
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
Status: Enrolling
Updated: 7/17/2015
Oklahoma University
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Breast and Cervical Cancer Educational Intervention for Latinas in Western New York
Investigating a Breast and Cervical Cancer Intervention for Latinas in Western New York
Status: Enrolling
Updated:  7/21/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Breast and Cervical Cancer Educational Intervention for Latinas in Western New York
Investigating a Breast and Cervical Cancer Intervention for Latinas in Western New York
Status: Enrolling
Updated: 7/21/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Research Investigation of Soy and Estrogen
Effects of Estradiol and Soy on Menopausal Symptoms
Status: Enrolling
Updated:  7/23/2015
University of Illinois at Chicago
mi
from
Chicago, IL
Research Investigation of Soy and Estrogen
Effects of Estradiol and Soy on Menopausal Symptoms
Status: Enrolling
Updated: 7/23/2015
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
The Safety Evaluation of Silver Alginate (Algidex™) Dressing in Very Low Birth Weight (VLBW) Infants
Status: Enrolling
Updated:  7/27/2015
Baylor University Medical Center - Women and Children's Services
mi
from
Dallas, TX
The Safety Evaluation of Silver Alginate (Algidex™) Dressing in Very Low Birth Weight (VLBW) Infants
Status: Enrolling
Updated: 7/27/2015
Baylor University Medical Center - Women and Children's Services
mi
from
Dallas, TX
Click here to add this to my saved trials
Cranial Cup Use for the Prevention of Positional Head Shape Deformity in the NICU
Cranial Cup Use for the Prevention of Positional Head Shape Deformity in the NICU
Status: Enrolling
Updated:  7/29/2015
Children's Hospital Boston
mi
from
Boston, MA
Cranial Cup Use for the Prevention of Positional Head Shape Deformity in the NICU
Cranial Cup Use for the Prevention of Positional Head Shape Deformity in the NICU
Status: Enrolling
Updated: 7/29/2015
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials